Vendor review
Lisa Biopeptide reviews
Lisa Biopeptide reviews from 75 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Lisa Biopeptide legit? See what its vials showed.
What the lab tests show
75 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 24, 2026 | GHK-Cu | 100 mg | Fail | View | |
| Aug 21, 2026 | Tirzepatide | 99.9 % | 61.2 mg of 60 mg (2 %) | Pass | View |
| Aug 21, 2026 | Retatrutide | 99.8 % | 64 mg of 60 mg (7 %) | Pass | View |
| Aug 9, 2026 | Tesamorelin | 99.7 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 96.5 % | 30.2 mg of 30 mg (1 %) | Pass | View |
| Aug 4, 2026 | Retatrutide | 30 mg | Fail | View | |
| Aug 3, 2026 | Tirzepatide | 98.5 % | 15.2 mg of 15 mg (1 %) | Pass | View |
| Aug 2, 2026 | TB-500 | 99.6 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Jul 30, 2026 | Cagrilintide | 10 mg | Fail | View | |
| Jul 22, 2026 | GHK-Cu | 99.9 % | 39 mg of 50 mg (-22 %) | Pass | View |
| Jul 22, 2026 | BPC-157 | 99.3 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Jul 22, 2026 | Tirzepatide | 99.9 % | 34.8 mg of 30 mg (16 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 15 mg | Fail | View | |
| Jul 1, 2026 | Retatrutide | 99.9 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jul 1, 2026 | BPC-157 | 99.9 % | 4.79 mg of 5 mg (-4 %) | Pass | View |
| Jul 1, 2026 | GHK-Cu | 99.9 % | 118.1 mg of 100 mg (18 %) | Pass | View |
| Jun 8, 2026 | Retatrutide | 60 mg | Fail | View | |
| Jun 8, 2026 | Cagrilintide | 10 mg | Fail | View | |
| Jun 8, 2026 | Tirzepatide | 80 mg | Fail | View | |
| Jun 4, 2026 | GHK-Cu | 99.7 % | 93.2 mg of 100 mg (-7 %) | Pass | View |
| Jun 4, 2026 | Tesamorelin | 99.6 % | 24.8 mg of 20 mg (24 %) | Pass | View |
| May 6, 2026 | Tesamorelin | 99.9 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| May 6, 2026 | GHK-Cu | 99.9 % | 56 mg of 50 mg (12 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 15.8 mg of 20 mg (-21 %) | Pass | View |
| Apr 28, 2026 | GHK-Cu | 99.9 % | 61.5 mg of 50 mg (23 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 9.17 mg of 10 mg (-8 %) | Pass | View |
| Apr 28, 2026 | TB-500 | 98.3 % | 8.77 mg of 10 mg (-12 %) | Pass | View |
| Apr 27, 2026 | Retatrutide | 99.7 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 9.68 mg of 10 mg (-3 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.4 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.5 % | 15.9 mg of 15 mg (6 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.2 % | 5.11 mg of 5 mg (2 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 14.8 mg of 15 mg (-1 %) | Pass | View |
| Apr 21, 2026 | Retatrutide | 99.8 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 17.9 mg of 20 mg (-11 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 8.77 mg of 10 mg (-12 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 43.3 mg of 50 mg (-13 %) | Pass | View |
| Mar 18, 2026 | Tesamorelin | 99.9 % | 5.16 mg of 5 mg (3 %) | Pass | View |
| Mar 18, 2026 | Tesamorelin | 99.9 % | 9.87 mg of 10 mg (-1 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 41.5 mg of 50 mg (-17 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 27.5 mg of 30 mg (-8 %) | Pass | View |
| Mar 10, 2026 | Cagrilintide | 99.9 % | 5.25 mg of 5 mg (5 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 7.98 mg of 10 mg (-20 %) | Pass | View |
| Mar 6, 2026 | BPC-157 | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 6, 2026 | TB-500 | 97.8 % | 9.75 mg of 10 mg (-3 %) | Pass | View |
| Mar 6, 2026 | GHK-Cu | 99.9 % | 85.5 mg of 100 mg (-15 %) | Pass | View |
| Mar 4, 2026 | BPC-157 | 99.39 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Mar 4, 2026 | TB-500 | 99.53 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.85 % | 32.4 mg of 30 mg (8 %) | Pass | View |
| Mar 3, 2026 | Tirzepatide | 74.5 % | 2 mg of 5 mg (-60 %) | Pass | View |
| Mar 2, 2026 | BPC-157 | 98.7 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 2, 2026 | BPC-157 | 98.4 % | 10 mg of 10 mg (0 %) | Pass | View |
| Mar 2, 2026 | Tesamorelin | 99.9 % | 11 mg of 10 mg (10 %) | Pass | View |
| Mar 2, 2026 | GHK-Cu | 99.38 % | 44 mg of 50 mg (-12 %) | Pass | View |
| Mar 1, 2026 | Retatrutide | 99.8 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Mar 1, 2026 | Tirzepatide | 99.9 % | 30.9 mg of 30 mg (3 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 94.5 % | 22.5 mg of 20 mg (13 %) | Pass | View |
| Feb 20, 2026 | Tesamorelin | 99.6 % | 9.54 mg of 10 mg (-5 %) | Pass | View |
What Lisa Biopeptide sells
No current listings on record.
About Lisa Biopeptide
Finnrick has tested 75 samples from Lisa Biopeptide across 7 products.